Hexalen

Known as: MGI Pharma Brand of Altretamine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Drug sterilization with ionizing radiation is a well-established technology, which is constantly extending to several products… (More)
Is this relevant?
Review
2008
Review
2008
Significant disparities in cervical cancer incidence and mortality rates among minority groups have been documented in the United… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
Review
2008
Review
2008
Among the myriad of alterations present in cancer cells are an abundance of aberrant mRNA transcripts. Whether abnormal gene… (More)
Is this relevant?
2004
2004
PURPOSE We performed a Phase I and pharmacokinetic study to determine the maximum tolerated dose of irofulven (6… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2002
Review
2002
Cynthia N. Rittenberg, RN, MN, AOCN ®, is president of Rittenberg Oncology Consulting in Metairie, LA, and executive director of… (More)
Is this relevant?
2002
2002
Irofulven is a novel, small molecular weight semisynthetic compound, derived from a family of mushroom toxins known as illudins… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Review
2002
Review
2002
MGI Pharma is developing irofulven, a semi-synthetic compound derived from illudin S, a toxin from the Omphalotus illudens… (More)
Is this relevant?
2000
2000
Combination chemotherapy with hexamethylmelamine (hexalen, altretamine, hexastat), 100 mg, thrice a day, per os, 14 days (out of… (More)
Is this relevant?
1994
1994
 
Is this relevant?